These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38064587)

  • 1. Colchicine Leads the Charge in Post-percutaneous Coronary Intervention Anti-inflammatory Defense.
    Martinez Naya N; Toldo S; Abbate A
    J Cardiovasc Pharmacol; 2024 Mar; 83(3):231-233. PubMed ID: 38064587
    [No Abstract]   [Full Text] [Related]  

  • 2. Different Anti-inflammatory Drugs on High-Sensitivity C-Reactive Protein in Patients After Percutaneous Coronary Intervention: A Pilot Randomized Clinical Trial.
    Yu M; Zhu ZF; Yang F; Yuan YF; Liao SD; Liu ML; Cheng X
    J Cardiovasc Pharmacol; 2024 Mar; 83(3):234-242. PubMed ID: 37944130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Acute Colchicine Administration Prior to Percutaneous Coronary Intervention: COLCHICINE-PCI Randomized Trial.
    Shah B; Pillinger M; Zhong H; Cronstein B; Xia Y; Lorin JD; Smilowitz NR; Feit F; Ratnapala N; Keller NM; Katz SD
    Circ Cardiovasc Interv; 2020 Apr; 13(4):e008717. PubMed ID: 32295417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention.
    Aw KL; Koh A; Lee HL; Kudzinskas A; De Palma R
    Open Heart; 2022 Jan; 9(1):. PubMed ID: 34992158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine in Coronary Artery Disease: An Old Acquaintance in New Attire?
    Giannopoulos G; Angelidis C; Papoutsidakis N; Panagopoulou V; Cleman MW; Lekakis J; Deftereos S
    Curr Med Chem; 2015; 22(36):4177-88. PubMed ID: 26467282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory (Colchicine) Treatment for Secondary Prevention in Coronary Artery Disease: A Milestone has Been Met.
    Moroni F; Abbate A
    J Cardiovasc Pharmacol; 2023 Oct; 82(4):237-240. PubMed ID: 37535948
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Colchicine in the Treatment of Patients With Coronary Artery Disease: A Mini-Review.
    Yong J; Tian J; Jiang W; Zhao X; Zhang H; Song X
    Clin Ther; 2022 Aug; 44(8):1150-1159. PubMed ID: 35907660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There a Role for Colchicine in Acute Coronary Syndromes?
    Nidorf SM; Verma S
    J Am Heart Assoc; 2015 Aug; 4(8):e002372. PubMed ID: 26304942
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose colchicine for coronary artery disease.
    Med Lett Drugs Ther; 2021 Apr; 63(1621):54-55. PubMed ID: 33830969
    [No Abstract]   [Full Text] [Related]  

  • 12. Colchicine administration for percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Fu C; Wang B
    Am J Emerg Med; 2021 Aug; 46():121-125. PubMed ID: 33744748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine in Stable Coronary Artery Disease.
    Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
    Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
    Alam M; Kontopantelis E; Mamas MA; Savinova OV; Jhaveri A; Siddiqui E; Jhamnani S
    Coron Artery Dis; 2023 May; 34(3):210-215. PubMed ID: 36762630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of colchicine on patients with acute and chronic coronary artery disease.
    Madanchi M; Young M; Tersalvi G; Maria Cioffi G; Attinger-Toller A; Cuculi F; Kurmann R; Bossard M
    Eur J Intern Med; 2024 Jul; 125():1-9. PubMed ID: 38238134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Trials.
    Kofler T; Kurmann R; Lehnick D; Cioffi GM; Chandran S; Attinger-Toller A; Toggweiler S; Kobza R; Moccetti F; Cuculi F; Jolly SS; Bossard M
    J Am Heart Assoc; 2021 Aug; 10(16):e021198. PubMed ID: 34369166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colchicine and coronary artery disease: a virtuous adoption.
    Angelini F; Bocchino PP; Imazio M
    Eur Heart J; 2021 Jul; 42(28):2796-2797. PubMed ID: 33496321
    [No Abstract]   [Full Text] [Related]  

  • 19. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
    Martínez GJ; Robertson S; Barraclough J; Xia Q; Mallat Z; Bursill C; Celermajer DS; Patel S
    J Am Heart Assoc; 2015 Aug; 4(8):e002128. PubMed ID: 26304941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine may decrease cardiovascular events in patients with coronary artery disease.
    Griffin L; Groce J; Conway S
    J Fam Pract; 2022 Jul; 71(6):E1-E3. PubMed ID: 35994760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.